Ms. Hassan (for herself and Mr. Braun) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To improve the actions available to eligible product developers in the event of delays in receiving covered product for purposes of generic drug or biosimilar biological product development.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Improved Access to Affordable Medications Act. S. 1120. 118th
Cong., 1st
sess., Introduced in Senate March 30, 2023. https://www.govinfo.gov/app/details/BILLS-118s1120is.
APA
Congress, Senate (2023, March 30). Improved Access to Affordable Medications Act (S. 1120 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118s1120is.
MLA
United States, Congress, Senate. Improved Access to Affordable Medications Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118s1120is. 118th Congress, S. 1120, Introduced in Senate 30 Mar. 2023.
Bluebook
S.1120 - 118th Congress (2023-2024): Improved Access to Affordable Medications Act, S.1120, 118th Cong. (2023), https://www.govinfo.gov/app/details/BILLS-118s1120is.
